Associates Llc Brightstar serves as Executive at Deciphera Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Associates Llc Brightstar has executed 6 insider transactions totaling $44.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 22, 2024 involved exercising options for 48,136 shares valued at $0.
Associates Llc Brightstar currently holds 23,107,844 shares of Deciphera Pharmaceuticals, Inc. (DCPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Associates Llc Brightstar has been a net buyer of DCPH stock. They have purchased $44.8M and sold $0 worth of shares.
Associates Llc Brightstar's most recent insider trade was on Apr 22, 2024, when they sold 48,136 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 28, 2023 | DCPH | $0 | Exercise | 2,427,693 | $N/A | Discretionary |
| Jan 24, 2023 | DCPH | $30.0M | Purchase | 1,666,666 | $18.00 | Discretionary |
| Apr 29, 2022 | DCPH | $14.8M | Purchase | 1,478,978 | $10.00 | Discretionary |
| Oct 2, 2017 | DCPH | $0 | Conversion | 16,572,370 | $N/A | Discretionary |